This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, R
Right arrow Articles by Verma, I M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müller, R
Right arrow Articles by Verma, I M

 Previous Article  |  Next Article 

Mol Cell Biol. 1983 June; 3(6): 1062-1069

Transcription of c-onc genes c-rasKi and c-fms during mouse development.

R Müller, D J Slamon, E D Adamson, J M Tremblay, D Müller, M J Cline and I M Verma

ABSTRACT

We investigated the expression of cellular sequences c-rasKi and c-fms, which are homologous to the oncogenes of Kirsten rat sarcoma virus and the McDonough strain of feline sarcoma virus, during murine development and in a variety of mouse tissues. The c-rasKi gene was found to be transcribed into two mRNA species of approximately 2.0 and 4.4 kilobases, whereas a single c-fms-related transcript of approximately 3.7 kilobases was identified. The c-rasKi gene appeared to be expressed ubiquitously, since similar levels of transcripts were observed in embryos, fetuses, extraembryonal structures, and a variety of postnatal tissues. In contrast, significant expression of c-fms was found to be confined to the placenta and extraembryonal membranes (i.e., combined yolk sac and amnion). The concentration of c-fms transcripts in the placenta increased approximately 15-fold (relative to day-7 to day-9 conceptuses) during development before reaching a plateau at day 14 to 15 of gestation. The time course of cfms expression in the extraembryonal membranes appeared to parallel the stage-specific pattern observed in the placenta. The level of c-fms transcripts in the extraembryonal tissues reached a level which was approximately 20- to 50-fold greater than that in the fetus. These findings suggest that the c-fms gene product may play a role in differentiation of extraembryonal structures or in transport processes occurring in these tissues. Our results indicate that the c-onc genes analyzed in the present study exert essentially different functions during mouse development.

Mol Cell Biol. 1983 June; 3(6): 1062-1069




This article has been cited by other articles:

  • Khalaf, W. F., Yang, F.-C., Chen, S., White, H., Bessler, W., Ingram, D. A., Clapp, D. W. (2007). K-ras Is Critical for Modulating Multiple c-kit-Mediated Cellular Functions in Wild-Type and Nf1+/- Mast Cells. J. Immunol. 178: 2527-2534 [Abstract] [Full Text]  
  • Matallanas, D., Arozarena, I., Berciano, M. T., Aaronson, D. S., Pellicer, A., Lafarga, M., Crespo, P. (2003). Differences on the Inhibitory Specificities of H-Ras, K-Ras, and N-Ras (N17) Dominant Negative Mutants Are Related to Their Membrane Microlocalization. J. Biol. Chem. 278: 4572-4581 [Abstract] [Full Text]  
  • Wang, Y., Waldron, R. T., Dhaka, A., Patel, A., Riley, M. M., Rozengurt, E., Colicelli, J. (2002). The RAS Effector RIN1 Directly Competes with RAF and Is Regulated by 14-3-3 Proteins. Mol. Cell. Biol. 22: 916-926 [Abstract] [Full Text]  
  • Bar-Sagi, D. (2001). A Ras by Any Other Name. Mol. Cell. Biol. 21: 1441-1443 [Full Text]  
  • Murase, S.-i., Hayashi, Y. (1998). Expression Pattern and Neurotrophic Role of the c-fms Proto-Oncogene M-CSF Receptor in Rodent Purkinje Cells. J. Neurosci. 18: 10481-10492 [Abstract] [Full Text]  
  • Johnson, L., Greenbaum, D., Cichowski, K., Mercer, K., Murphy, E., Schmitt, E., Bronson, R. T., Umanoff, H., Edelmann, W., Kucherlapati, R., Jacks, T. (1997). K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11: 2468-2481 [Abstract] [Full Text]  
  • Wick, M, Burger, C, Brusselbach, S, Lucibello, F., Muller, R (1994). Identification of serum-inducible genes: different patterns of gene regulation during G0-->S and G1-->S progression. J. Cell Sci. 107: 227-239 [Abstract]  
  • Mumberg, D, Lucibello, F C, Schuermann, M, Muller, R (1991). Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins.. Genes Dev. 5: 1212-1223 [Abstract]  
  • Sherr, C. J., Rettenmier, C.W., Roussel, M.F. (1988). Macrophage Colony-stimulating Factor, CSF-1, and Its Proto-oncogene-encoded Receptor. Cold Spring Harb Symp Quant Biol 53: 521-530 [Abstract]  
  • Weinberg, R. (1985). The action of oncogenes in the cytoplasm and nucleus. Science 230: 770-776 [Abstract]  
  • Rettenmier, C., Chen, J., Roussel, M., Sherr, C. (1985). The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity. Science 228: 320-322 [Abstract]  
  • Birchmeier, C., Broek, D., Toda, T., Powers, S., Kataoka, T., Wigler, M. (1985). Conservation and Divergence of RAS Protein Function during Evolution. Cold Spring Harb Symp Quant Biol 50: 721-725 [Abstract]  
  • CLINE, M. J., SLAMON, D. J., LIPSICK, J. S. (1984). Oncogenes: Implications for the Diagnosis and Treatment of Cancer. ANN INTERN MED 101: 223-233 [Abstract]  
  • Slamon, D., deKernion, J., Verma, I., Cline, M. (1984). Expression of cellular oncogenes in human malignancies. Science 224: 256-262 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»